查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1787223

全球新型阴道手术市场

Neovaginal Surgery
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球新阴道手术市场规模将达到 15 亿美元

全球新阴道手术市场规模预计在2024年为12亿美元，预计到2030年将达到15亿美元，在2024-2030年的分析期内，复合年增长率为3.9%。变性手术是本报告分析的细分市场之一，预计其复合年增长率为3.6%，到分析期结束时规模将达到8.379亿美元。阴道外整形手术细分市场在分析期间的复合年增长率预计为4.5%。

美国市场规模估计为 3.33 亿美元，中国市场预计复合年增长率为 7.1%

美国新阴道手术市场规模预计2024年达到3.33亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到3.099亿美元，在2024-2030年的分析期间内，复合年增长率为7.1%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为1.6%和3.0%。在欧洲，德国的复合年增长率预计为2.2%。

全球新阴道手术市场－主要趋势与驱动因素摘要

为什么新阴道手术在现代医学中变得越来越重要？

新阴道成形术是重组和性别确认手术的一个高度专业化的领域，随着医学进步为需要阴道重组的患者扩大选择，该领域变得越来越重要。进行这种手术的原因多种多样，包括跨性别女性的性别确认手术、Mayer-Rokitansky-Kuster-Hauser (MRKH) 症候群等先天性疾病以及创伤或肿瘤治疗后的重组需求。手术技术的进步透过各种方法显着改善了治疗效果，从阴茎内翻阴道成形术和肠阴道成形术到非手术选择，如组织扩张和自体皮肤移植阴道成形术。手术材料和术后护理的进步提高了功能性、美观效果和患者满意度。人们对跨性别医疗保健的接受度和认识度不断提高也促进了对新阴道成形术的需求不断增长，并导致该医疗领域的专业化程度不断提高。随着人们意识和医学专业知识的不断发展，新阴道成形术为寻求重组介入的人提供了改变生活的解决方案，带来了身体和心理上的益处。

新阴道手术市场面临哪些挑战？

儘管新阴道手术的重要性日益增加，但它市场仍面临着影响可及性、治疗结果和监管核准的若干挑战。其中一个最显着的障碍是专门从事阴道成形术和其他重组手术的训练有素的外科医生数量有限。这些复杂的手术需要丰富的外科专业知识，而且只有在专门的医疗中心才能进行。此外，这些手术的高昂费用给许多患者带来了经济挑战，特别是在保险不涵盖性别肯定护理和重组手术的地区。另一个挑战是术后併发症的风险，如狭窄、感染疾病和功能限制，这些併发症需要长期的后续观察结果不一致。由于各国对变性手术的监管接受程度不同，道德和法律的考量也限制了市场的成长。与跨性别医疗保健和重组手术相关的耻辱感进一步限制了人们获得医疗服务的机会，并阻碍了一些人寻求必要的医疗服务。应对这些挑战不仅需要医学创新，还需要政策改革、增加外科医生的培训机会以及提高社会对重组和性别认同保留手术的接受度。

科技进步如何重塑新阴道手术？

科技进步在提高新阴道手术的精准度、安全性和有效性方面发挥了关键作用。机器人辅助手术的整合提高了复杂手术的准确性，缩短了恢復时间，并最大限度地降低了传统手术技术的风险。此外，组织工程和再生医学的进步为建构功能性、生物相容性的新阴道结构提供了充满希望的解决方案。干细胞疗法和生物工程阴道组织的研究为改善长期手术效果开闢了新的可能性。另一项创新发展是使用3D列印机进行术前规划和患者专属手术导板，从而实现解剖学客製化并提高手术精准度。改进的术后护理策略，例如增强的疼痛管理和优化的扩张技术，进一步提升了患者体验和功能成功率。此外，远端医疗和数位健康平台的兴起，也增加了接受新阴道手术的患者获得术前咨询、术后监测和心理健康支援的机会。这些技术创新不仅提高了手术能力，而且增加了新阴道手术领域的可及性和以患者为中心的照护。

推动新阴道手术市场成长的因素是什么？

新阴道手术市场的成长受到多种因素的推动，包括变性手术需求的增加、手术技术的进步以及医疗保健政策的改善。人们对跨性别医疗需求的认识和接受度不断提高，导致对阴道成形术和其他变性手术的需求激增，从而鼓励医疗保健提供者扩大其提供的手术范围。此外，对 MRKH 症候群等先天性疾病的认识不断提高，导致需要阴道重组的个人的医疗干预增加。各国扩大的保险覆盖范围和政府资助的医疗保健计划也使得这些手术在经济上更容易接受。技术进步，特别是机器人辅助手术和生物工程组织的进步，进一步改善了手术效果并减少了併发症，吸引了更多寻求这些干预措施的患者。不断壮大的专科手术中心和多学科医疗团队网络正在提高整体护理品质并增强人们对手术选择的信心。随着社会对性别多样性和重组手术的态度不断演变，对新阴道手术的需求预计会增加，从而推动这一专业医疗领域的进一步创新和市场扩张。

部分

治疗类型（变性手术、阴道发育不全治疗手术、阴道闭锁性手术）

受访公司范例

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Chettawut Plastic Surgery Center
  • Conmed Corporation
  • Gonzalez-Fontana
  • Hologic, Inc.
  • Icahn School of Medicine at Mount Sinai
  • Intuitive Surgical, Inc.
  • Karl Storz SE & Co. KG
  • KESSEL Medintim GmbH
  • Medtronic plc
  • Mylan NV
  • Olympus Corporation
  • Owen Mumford Ltd.
  • Phuket Plastic Surgery Institute（PPSI）
  • Smith & Nephew plc
  • Stryker Corporation
  • Thermo Fisher Scientific Inc.
  • Vuvatech

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global 特定产业产业SLM 的典型规范，而是建立了一个从世界各地专家收集的内容库，包括影片录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP32317

Global Neovaginal Surgery Market to Reach US$1.5 Billion by 2030

The global market for Neovaginal Surgery estimated at US$1.2 Billion in the year 2024, is expected to reach US$1.5 Billion by 2030, growing at a CAGR of 3.9% over the analysis period 2024-2030. Sex Reassignment Surgery, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$837.9 Million by the end of the analysis period. Growth in the Vaginal Agenesis Treatment Surgery segment is estimated at 4.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$333.0 Million While China is Forecast to Grow at 7.1% CAGR

The Neovaginal Surgery market in the U.S. is estimated at US$333.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$309.9 Million by the year 2030 trailing a CAGR of 7.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 3.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.2% CAGR.

Global Neovaginal Surgery Market - Key Trends & Drivers Summarized

Why Is Neovaginal Surgery Gaining Significance in Modern Medicine?

Neovaginal surgery, a highly specialized branch of reconstructive and gender-affirming surgery, is becoming increasingly important as medical advancements expand options for individuals requiring vaginal reconstruction. This surgical procedure is performed for various medical and personal reasons, including gender-affirming procedures for transgender women, congenital conditions such as Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome, and reconstructive needs following trauma or oncological treatments. The evolution of surgical techniques has significantly improved outcomes, with approaches ranging from penile inversion vaginoplasty and intestinal vaginoplasty to non-surgical options such as tissue expansion and vaginoplasty using autologous skin grafts. Advancements in surgical materials and postoperative care have enhanced functionality, aesthetic outcomes, and patient satisfaction. The growing acceptance and recognition of transgender healthcare have also contributed to the rising demand for neovaginal procedures, leading to increased specialization in this medical field. As awareness and medical expertise continue to evolve, neovaginal surgery is providing life-changing solutions for individuals seeking reconstructive interventions, offering both physical and psychological benefits.

What Are the Challenges Facing the Neovaginal Surgery Market?

Despite its growing importance, the neovaginal surgery market faces several challenges that impact accessibility, procedural outcomes, and regulatory approvals. One of the most significant barriers is the limited availability of highly trained surgeons specializing in vaginoplasty and other reconstructive techniques. The complexity of the procedure requires extensive surgical expertise, making it accessible only in specialized medical centers. Additionally, the high cost associated with these surgeries poses financial challenges for many patients, particularly in regions where gender-affirming care or reconstructive surgeries are not covered by insurance. Another challenge is the risk of postoperative complications, including stenosis, infections, and functional limitations, which require long-term follow-up and care. Furthermore, there is a persistent lack of standardized protocols for post-surgical rehabilitation, leading to variability in patient outcomes. Ethical and legal considerations also play a role in limiting market growth, as different countries have varying levels of regulatory acceptance regarding gender-affirming surgeries. The stigma associated with transgender healthcare and reconstructive procedures further restricts access and discourages some individuals from seeking necessary medical care. Addressing these challenges requires not only medical innovation but also policy reforms, increased training opportunities for surgeons, and broader societal acceptance of reconstructive and gender-affirming procedures.

How Are Technological Advancements Reshaping Neovaginal Surgery?

Technological advancements are playing a pivotal role in improving the precision, safety, and effectiveness of neovaginal surgery. The integration of robotic-assisted surgery is enhancing the accuracy of complex procedures, reducing recovery times, and minimizing risks associated with traditional surgical techniques. Additionally, advancements in tissue engineering and regenerative medicine are offering promising solutions for creating functional and biologically compatible neovaginal structures. Research into stem cell therapies and bioengineered vaginal tissues has opened new possibilities for improving long-term surgical outcomes. Another transformative development is the use of 3D printing for pre-surgical planning and patient-specific surgical guides, allowing for better anatomical customization and improved surgical accuracy. Improved postoperative care strategies, including enhanced pain management and optimized dilation techniques, are further enhancing patient experience and functional success rates. Moreover, the rise of telemedicine and digital health platforms is increasing access to preoperative consultations, postoperative monitoring, and mental health support for patients undergoing neovaginal procedures. These technological innovations are not only advancing surgical capabilities but also improving accessibility and patient-centered care in the field of neovaginal surgery.

What Is Driving the Growth of the Neovaginal Surgery Market?

The growth in the neovaginal surgery market is driven by several factors, including increasing demand for gender-affirming procedures, advancements in surgical techniques, and improved healthcare policies. The rising visibility and acceptance of transgender healthcare needs have led to a surge in demand for vaginoplasty and other gender-affirming surgeries, prompting healthcare providers to expand their offerings. Additionally, congenital conditions such as MRKH syndrome are becoming more widely recognized, leading to increased medical interventions for individuals requiring vaginal reconstruction. The expansion of insurance coverage and government-backed healthcare initiatives in various countries is also making these procedures more financially accessible. Technological advancements, particularly in robotic-assisted surgery and bioengineered tissues, are further enhancing surgical outcomes and reducing complications, attracting more patients to seek these interventions. The growing network of specialized surgical centers and multidisciplinary healthcare teams is improving the overall quality of care, fostering greater confidence in surgical options. As societal attitudes toward gender diversity and reconstructive surgery continue to evolve, the demand for neovaginal procedures is expected to increase, driving further innovation and market expansion in this specialized field of medicine.

SCOPE OF STUDY:

The report analyzes the Neovaginal Surgery market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Treatment Type (Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery, Vaginal Atresia Treatment Surgery)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Chettawut Plastic Surgery Center
  • Conmed Corporation
  • Gonzalez-Fontana
  • Hologic, Inc.
  • Icahn School of Medicine at Mount Sinai
  • Intuitive Surgical, Inc.
  • Karl Storz SE & Co. KG
  • KESSEL Medintim GmbH
  • Medtronic plc
  • Mylan N.V.
  • Olympus Corporation
  • Owen Mumford Ltd.
  • Phuket Plastic Surgery Institute (PPSI)
  • Smith & Nephew plc
  • Stryker Corporation
  • Thermo Fisher Scientific Inc.
  • Vuvatech

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Neovaginal Surgery - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Gender-Affirming Care Policies Across Healthcare Systems Strengthens Business Case for Neovaginal Surgery
    • Growing Awareness and Acceptance of Transgender Healthcare Expands Addressable Market Opportunity
    • Advances in Surgical Techniques and Tissue Engineering Drive Adoption of Neovaginal Surgery Procedures
    • Increasing Insurance Coverage for Gender Reassignment Surgeries Propels Market Growth
    • Expansion of Transgender-Friendly Healthcare Facilities Accelerates Demand for Specialized Surgical Services
    • Surge in Medical Tourism for Gender-Affirming Procedures Throws the Spotlight on High-Quality Surgical Offerings
    • Development of Minimally Invasive Neovaginal Construction Methods Spurs Growth in Patient Preference
    • Emergence of Robotic-Assisted Surgery Enhances Precision and Drives Premium Pricing Potential
    • Strong Advocacy and Support from LGBTQ+ Organizations Strengthens Policy Push and Market Access
    • Integration of Regenerative Medicine Techniques Expands Innovation Frontier and Market Attractiveness
    • Rising Number of Transgender Individuals Seeking Transition Surgeries Generates Sustained Demand
    • Inclusion of Neovaginal Surgery in National Healthcare Guidelines Drives Institutional Adoption
    • Increasing Collaboration Between Medical Institutions and Transgender Health Experts Bolsters Clinical Standards
    • Regulatory Support for Gender-Affirming Care Accelerates Hospital and Clinic Participation
    • Social Media and Influencer-Led Education Campaigns Spur Awareness and Demand Among Younger Demographics
    • Improved Post-Operative Outcomes and Patient Satisfaction Rates Propel Long-Term Market Confidence
    • Training and Certification Programs for Surgeons Drive Growth of Skilled Workforce and Procedure Uptake
    • Expanding Availability of Customizable Surgical Techniques Enhances Patient-Centric Approaches and Market Differentiation
    • Advances in Preoperative Imaging and Simulation Tools Strengthen Case for Personalized Surgical Planning
    • Ethical and Legal Debates Around Access to Gender-Affirming Care Create Regulatory Complexity and Market Challenges
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Neovaginal Surgery Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Neovaginal Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Neovaginal Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Neovaginal Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Sex Reassignment Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Sex Reassignment Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Sex Reassignment Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Vaginal Agenesis Treatment Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Vaginal Agenesis Treatment Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Vaginal Agenesis Treatment Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Vaginal Atresia Treatment Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Vaginal Atresia Treatment Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Vaginal Atresia Treatment Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Neovaginal Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: USA 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: Canada 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • JAPAN
    • Neovaginal Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: Japan 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • CHINA
    • Neovaginal Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: China 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • EUROPE
    • Neovaginal Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Neovaginal Surgery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Neovaginal Surgery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: Europe 15-Year Perspective for Neovaginal Surgery by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Europe 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • FRANCE
    • Neovaginal Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: France 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • GERMANY
    • Neovaginal Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Germany 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Italy 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Neovaginal Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: UK 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Spain 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Russia 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Rest of Europe 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Neovaginal Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Neovaginal Surgery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Neovaginal Surgery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Asia-Pacific 15-Year Perspective for Neovaginal Surgery by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Asia-Pacific 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Neovaginal Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Australia 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • INDIA
    • Neovaginal Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: India 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: South Korea 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Neovaginal Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Neovaginal Surgery by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Neovaginal Surgery by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Latin America 15-Year Perspective for Neovaginal Surgery by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Latin America 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Argentina 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Brazil 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Mexico 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of Latin America 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Neovaginal Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Neovaginal Surgery by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Neovaginal Surgery by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Middle East 15-Year Perspective for Neovaginal Surgery by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Middle East 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Iran 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Israel 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Saudi Arabia 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: UAE 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of Middle East 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030
  • AFRICA
    • Neovaginal Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Neovaginal Surgery by Treatment Type - Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Africa 15-Year Perspective for Neovaginal Surgery by Treatment Type - Percentage Breakdown of Value Sales for Sex Reassignment Surgery, Vaginal Agenesis Treatment Surgery and Vaginal Atresia Treatment Surgery for the Years 2015, 2025 & 2030

IV. COMPETITION